Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDX
3326
DELISTED
AvidXchange
AVDX
| $459K | ﹤0.01% |
38,052
+11,334
| +42% | +$129K |
|
|
SAVE
3327
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $458K | ﹤0.01% |
+125,000
| New | +$484K |
|
3328
Vaalco Energy
EGY
$562M
| $455K | ﹤0.01% |
72,621
-8,654
| -11% | -$55.8K |
|
|
SCS
3329
DELISTED
Steelcase
SCS
| $455K | ﹤0.01% |
35,129
+4,875
| +16% | +$62.1K |
|
3330
Carter's
CRI
$1.43B
| $455K | ﹤0.01% |
7,344
-15,541
| -68% | -$1.08M |
|
3331
Community Health Systems
CYH
$382M
| $455K | ﹤0.01% |
135,378
+109,343
| +420% | +$368K |
|
3332
Savara
SVRA
$1.08B
| $455K | ﹤0.01% |
112,818
+95,498
| +551% | +$425K |
|
3333
Spyre Therapeutics
SYRE
$8.5B
| $454K | ﹤0.01% |
19,320
-12,437
| -39% | -$420K |
|
3334
Iridium Communications
IRDM
$4.7B
| $453K | ﹤0.01% |
17,034
-27,393
| -62% | -$771K |
|
3335
Ingles Markets
IMKTA
$1.72B
| $453K | ﹤0.01% |
6,596
+1,756
| +36% | +$127K |
|
3336
Schneider National
SNDR
$6.17B
| $452K | ﹤0.01% |
18,689
-20,614
| -52% | -$456K |
|
3337
DXP Enterprises
DXPE
$2.3B
| $451K | ﹤0.01% |
9,847
+565
| +6% | +$28.5K |
|
|
CWEN.A
3338
DELISTED
Clearway Energy Class A
CWEN.A
| $451K | ﹤0.01% |
19,917
+2,813
| +16% | +$65.7K |
|
3339
Gossamer Bio
GOSS
$101M
| $450K | ﹤0.01% |
500,003
-1,787,777
| -78% | -$1.34M |
|
3340
Fulgent Genetics
FLGT
$558M
| $448K | ﹤0.01% |
22,856
+2,173
| +11% | +$45.4K |
|
|
SLNO
3341
DELISTED
Soleno Therapeutics
SLNO
| $447K | ﹤0.01% |
10,948
-86,806
| -89% | -$3.68M |
|
3342
National Grid
NGG
$79.3B
| $446K | ﹤0.01% |
8,333
-1,640
| -16% | -$98.9K |
|
3343
CALL
Alcoa
AA
$11.3B
| $446K | ﹤0.01% |
+11,200
| New | +$433K |
|
|
INVX
3344
Innovex International
INVX
$1.8B
| $445K | ﹤0.01% |
23,949
+1,802
| +8% | +$35K |
|
3345
Zillow
ZG
$7.85B
| $445K | ﹤0.01% |
9,885
-18,214
| -65% | -$786K |
|
3346
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.05B
| $444K | ﹤0.01% |
5,871
+4,106
| +233% | +$292K |
|
|
BAND
3347
Bandwidth Inc
BAND
$1.19B
| $443K | ﹤0.01% |
26,218
+3,999
| +18% | +$75.5K |
|
3348
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.9B
| $441K | ﹤0.01% |
13,116
-1,195
| -8% | -$40.7K |
|
3349
Ocular Therapeutix
OCUL
$1.83B
| $440K | ﹤0.01% |
64,310
-53,995
| -46% | -$333K |
|
3350
Virgin Galactic
SPCE
$315M
| $439K | ﹤0.01% |
52,062
-25,684
| -33% | -$466K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.